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A B ST R A C T
Urovesical dysautonom ic symptoms are present in 27-97%  of the patients with Parkinson's disease (PD) de­
pending on patients' selection criteria and methods used. The micturitional disturbances are typical o f pa­
tients with more severe PD. The authors studied the urovesical function in 23 PD patients aged 41-60 years 
and without subjective micturitional com plaints by uroflowmetry and ultrasound measurem ent o f  residual 
urine. Urovesical disturbances were established in 30,4% of the patients. The average results for M ax Flow  
Rate (M FR) were 21,85 ±5,49 ml/sec and for residual urine 27,83 ±25,58 ml. The most influencing factor was 
the severity o f the disease m easured by the UPDRS. Our results were important additions to the existing infor­
mation on the urovesical function in PD. Dysautonom ic micturitional disturbances were found even in pa­
tients without subjective complaints in the early stages o f the disease. Their degree correlated most closely to 
the severity o f PD. The necessity o f  specialized examiantions o f dysautonom ic urovesical symptom s imposes 
the presence o f a tailor-made patient approach for their early detection and adequate treatment.
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IN T R O D U C T IO N
Parkinson's disease (PD) is a multiple system disease af­
fecting the extrapyramidal and the autonomic nervous sys­
tems (ANS) as well. The urovesical disturbances are among 
the most frequent dysautonomic symptoms. Recent studies 
of PD showed their presence in 27-97% o f the patients. 
This different percentage depends on patients' selection cri­
teria and methods used. The most frequent symptoms are 
nicturia, frequency, and urgency. Some patients demon­
strate urinary retention, post voiding residual urine, hesi­
tancy and weak stream. Significant urinary incontinence is 
not common. It is more frequent in females and manifests 
like stress-incontinence. At the same time rigidity and 
bradykinesia can provoke the so-called 'pseudo- inconti­
nence' due to the slowed movements and the difficulties 
reaching the toilet (2,4,11 ).
Uroflowmetry is a noninvasive method for establishing dis­
turbances in the evacuatory phase of the micturitional cycle 
in PD. The most important parameters interpreted are maxi­
mal flow rate (MFR), volume o f evacuated urine and 
uroflow pattem. The micturitional disturbances are typical 
of patients with more severe PD. There are a few studies in
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early PD because the movement disorders precede the 
urovesical ones in 90% o f the cases (6).
The purpose o f our paper was to study the urovesical func­
tions in early-PD patients without subjective micturitional 
complaints by means o f uroflowmeay and ultrasound mea­
surement o f residual urine.
M A T E R IA L  A N D  M E T H O D S
Uroflowmetry and ultrasound measurements o f residual 
urine were performed in 23 PD patients (13 males and 10 
females) aged 41-60 (53,96 ±4,78) years with disease dura­
tion of 1-3 (2,17 ±0,78) years. All the persons were at 
Hoehn-Yahr stage I without subjective complaints sugges­
tive of urovesical dysfunction. Sixteen patients have 
right-sided movement disorders and seven have left-sided 
ones. PD was diagnosed in the Is1 Clinic o f Neurology o f St. 
Marina University Hospital o f Varna according to the crite­
ria o f the Bulgarian consensus for diagnostics and treatment 
of PD and o f the UK PD Society Brain Bank. Informed 
consent was obtained from all the participants in the study. 
None of them reported subjective micturitional complaints 
or other ANS disturbances. Patients with mechanical ob­
struction or other urologie or gynecologic diseases were not 
included. Intake of food or drugs influencing ANS was dis­
continued 24h before the examination.
Uroflowmetry and ultrasound measurements o f  residual 
urine were performed in the Clinic o f Urology o f St. Anna 
University Hospital o f Varna according to standard proce-
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dures using Medtronic Urodyn 1000 and Siemens Sonoline 
SL 100 apparatuses. The parameters assessed were the 
voiding time, the volume o f urine evacuated, MFR and the 
volume of residual urine. The widely accepted normal val­
ues were respected: minimal volume o f evacuated urine 
>100 ml, MFR >19.9 ml/sec and maximal volume o f resid­
ual urine <51 ml (3,5,9). The results obtained were ana­
lyzed by One Sample /-test, Pearson's correlation analysis, 
One-Way ANOVA and rang analysis (8).
R E SU L T S A N D  D ISC U SSIO N
MFR values are between 8,8-33,6 ml/sec (21,85 ±5,49) 
(95%, Cl 19,5-24,2). After applying rang analysis the val­
ues 8,8 and 33,6 ml/sec are not excluded (p>0,1 : r max= 
2,18; r min= 2,43; K=21).
Urinaiy flow rate depends on detrusor contraction and ure­
thral resistance. Uroflowmetry is applied to evaluate 
detrusor dysfunction and subvesical obstruction. Such dis­
turbances are comparatively often due to central level neu­
rological lesions (1,5).
The analysis using One Sample /-test shows statistically 
significant difference (p<0,01) between the average MFR 
and the accepted normal value. We have to bear in mind 
that normal values may vary for one and the same patient 
dependent on the volume o f voided urine, especially for 
values over 200ml (5,6).
According to MFR results, the patients are divided into two 
groups. Pathological values ue tween 8,8-18,7 ml/sec ( 16,26 
±3,4) are established in 30,4%. Most authors find a MFR 
decrease in 45-63% o f PD patients (7,10). Our results differ 
most likely due to the fact that all patients o f ours are in 
early stage (HY I) while other studies include patients from 
all stages. In the remaining 16 patients MFR values are nor­
mal varying between 20,7-33,6 ml/sec (24,3 ±4,31) (Table 
1).
The volume o f residual urine is between 0-100ml (27,83 
±25,58). Abnormal results are found out in 13% o f our pa­
tients. The analysis using One Sample t-test showed a sta­
tistically significant difference (p<0,01) for all examined 
between the average volume o f residual urine and the ac­
cepted normal value (50ml). These results for the patients 
with normal MFR are 0-50 ml (18,75 ±17,08). For those 
with pathological results the values are 0-100 ml (48,57 
±30,78). Most o f them have bigger quantities o f residual 
urine (Table 1).
It is well known that the volume o f residual urine is an indi­
rect index for bladder contractility. That is why its measure­
ment is an important addition to the evaluation of 
micturitional disturbances. According to literature data, 
16% o f PD patients have considerable volume o f residual 
urine. These results are from patients in all stages o f sever­
ity. Little attention is paid, however, to patients at stage I 
(6,7,10).
The analysis o f the relationship between MFR values and 
residual urine shows a statistically significant difference 
(p<0,01) that is strongly negative (Pearson's coefficient
r=-0,605), i. e. the volume o f residual urine decreases with 
increasing MFR.
Total score of UPDRS in all patients is 9-15 points (11,61 
±20,01). The score of part III o f the same scale is 4-6 points 
(4,7 ±0,77). In patients with normal MFR the total score is 
9-13 points (10,69 ±1,3) and that o f part III is 4-5 points 
(4,38 ±0,5). In the rest patients the points are 10-15 (13,71 
±1,79) and 4-6 (5,43 ±0,79), respectively (Table 1).
Table I. Values o f  patients with normal and  
pathological M FR according to UPDRS and  residual 
urine
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(18,7 ml ±17,08 ml)
0-100ml 
(48,5 ml ±30,78ml)
The predominating opinion is that the percentage of 
urovesical disturbances increases with the increase o f se­
verity and duration o f PD and that these disturbances are 
not an initial symptom. They appear most frequently in ad­
vanced disease and duration o f at least 3 years. In 90% of 
the cases the extrapyramidal symptoms precede the urolog­
ical (6). Other authors consider that the frequency o f symp­
toms correlate to the disease severity but neither to duration, 
nor to gender (4,10). We evaluate disease severity by means 
o f UPDRS total score and part III score. There was a statis­
tically significant (p<0,01), moderate to strong negative 
correlation (i= -0,550) between MFR and UPDRS total 
score for all patients. There was a statistically significant 
(p<0,01), moderate to strong negative correlation 
(r=-0,424) for the part III score, too. That means worsening 
o f urovesical function with decrease o f MFR closely asso­
ciated with the higher score, i.e. increase o f severity. Our re­
sults are in discrepancy with some other data indicating loss 
o f correlation between the cardinal motor symptoms and 
severity and the urovesical disturbances (5). The disease 
duration o f the patients is 2,17 ±0,78 years and there is no 
any statistically significant correlation to the values o f MFR 
as this is in accordance to the literature.
Age is another factor which is not o f significant importance 
for MFR results as shown by correlation analysis. Some au­
thors accept the role o f age as an important factor for the ap­
pearance o f urovesical disturbances (3,5,9). This discrep­
ancy is, probably, due to different selection criteria The up­
per age limit for our patients is 60 years and over this age 
the autonomic functions worsen even in healthy persons 
(9). By means of ANOVA no statistically significant differ­
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ences between the symptomatic side or the dominating mo­
tor symptom and MFR were established.
The urovesical symptoms in PD are due to the main patho­
logical process because basal ganglia inhibit the micturition 
centre and the dopaminergic deficit reduces detrusor inhibi­
tion (4,6). Fligher percentage of disturbances is found in pa­
tients with dominating rigidity and bradykinesia (3). De­
spite these observations the analysis o f our results showed 
no any significant correlation between MFR and the domi­
nating motor symptom.
Based on the analysis o f our results we could conclude that 
even at I Hoehn-Yahr stage there are urovesical distur­
bances in 39,4% of the patients despite the absent subjec­
tive complaints. These disturbances could be established by 
means o f laboratory examinations only (2,7,11). The sever­
ity o f PD evaluated by UPDRS is the factor correlating 
mostly with MFR decrease. Abnormal amount o f residual 
urine is found in 13%. Its volume is inversely proportional 
to the MFR value, i.e. higher MFR (normal urovesical 
function) is associated with smaller volume o f residual 
urine. Factors not influencing our results are gender, age, 
disease duration, dominating motor symptom and symp­
tomatic side. Our data differ slightly from those in the litera­
ture due, most probably, to the fact that the examined pa­
tients are at early stage, with short duration and at age under 
60 years. It is possible that with disease progressing and du­
ration advancing the above mentioned factors take their 
place in the pathogenesis o f the urovesical disturbances in 
PD.
C O N C L U SIO N
These results are important additions to the existing infor­
mation about the urovesical function in PD. Dysautonomic 
micturitional disturbances are found even in patients with­
out subjective complaints in the early stages o f the disease. 
Their degree correlates most closely to the severity o f PD. 
The necessity o f specialized examinations o f dysautonomic 
urovesical symptoms impose the presence o f  a tailor-made
patient approach for their early detection and adequate
treatment.
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